MDA 2023-0409
Parallel RandOmized STudy of personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation with Androgen Axis Suppression. A phase III multi-center study for men with detectable PSA after prostatectomy for prostate cancer
This study was created to personalize treatment for prostate cancer based on how aggressive the disease is and learn if apalutamide-based treatment can help to reduce fatigue and other side effects of treatment in participants who are being treated with radiation therapy for prostate cancer, as compared to standard therapy.